Physician profile
Mit Shah
NPI 1407412455
$2,716.09
in general payments reported to CMS, 2019-2025
18 companies · $1,176 in 2025
The $1,176 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $193 · 2022: $618 · 2023: $584 · 2024: $146 · 2025: $1,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $916.76 | 2023-2025 | Greenlight Xps, Bulkamid, Axonics |
| Intuitive Surgical, INC. | $403.90 | 2022 | |
| Olympus America INC. | $316.76 | 2022-2025 | Itind System |
| Teleflex LLC | $239.47 | 2022-2025 | Urolift, Barrigel |
| Ferring Pharmaceuticals INC. | $165.18 | 2025 | Adstiladrin |
| Procept Biorobotics Corporation | $127.90 | 2025 | |
| Astellas Pharma US INC | $105.93 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $86.87 | 2021 | |
| Dendreon Pharmaceuticals LLC | $64.00 | 2025 | Provenge |
| Accord Healthcare, INC. | $54.83 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $45.21 | 2025 | Keytruda, Welireg, Keytruda Qlex |
| Abbvie INC. | $40.97 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $37.34 | 2022 | |
| Progenics Pharmaceuticals, INC. | $26.27 | 2025 | |
| Pfizer INC. | $23.85 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.21 | 2025 | Altaviva |
| Sumitomo Pharma America, INC. | $19.28 | 2025 | Gemtesa |
| Coloplast Corp | $18.36 | 2023 | Saffron |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.